Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
|
| Posted
:
Wed, 04 Nov 2009 21:09:00 GMT |
| Author
:
Arena Pharmaceuticals, Inc. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
SAN DIEGO, Nov. 4, 2009 CA-ARNA-Conf-Call
SAN DIEGO, Nov. 4, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report third quarter 2009 financial results after the NASDAQ Global Market closes on Monday, November 9, 2009. The next morning, November 10, 2009, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, will host a conference call at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) to discuss the financial results for the third quarter 2009 and to provide a business and financial update.
The conference call may be accessed by dialing 888.452.4024 for domestic callers and 719.325.2385 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals' Third Quarter 2009 Financial Results Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About Arena Pharmaceuticals
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Arena Pharmaceuticals® and Arena® are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the timing, success and cost of Arena's lorcaserin program and other of its research and development programs; regulatory authorities may not find data from Arena's clinical trials and studies sufficient for regulatory approval; the timing and ability of Arena to receive regulatory approval for its drug candidates; results of clinical trials or preclinical studies may not be predictive of future results; clinical trials and studies may not proceed at the time or in the manner Arena expects or at all; Arena's ability to partner or commercialize lorcaserin or other of its compounds or programs; Arena's ability to obtain additional funds; Arena's ability to obtain and defend its patents; and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.
Contact: Arena Pharmaceuticals, Inc. Media Contact: Russo Partners
Jack Lief David Schull, President
President and CEO david.schull@russopartnersllc.com
858.717.2310
Cindy McGee
Manager, IR and Corporate Communications
858.453.7200, ext. 1479 Anthony J. Russo, Ph.D., CEO
tony.russo@russopartnersllc.com
212.845.4251
SOURCE Arena Pharmaceuticals, Inc.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Defence Minister Declares Security Forum "World-Class" Event HALIFAX, NOVA SCOTIA -- 11/22/09 --
As the three-day Halifax International Security Forum today wrapped up its final sessions, the Honourable Peter MacKay, Minister of National Defence and Minister for the Atlantic Gateway, declared the inaugural e..
Radiance Fine Jewelry 3rd Annual Holiday Party and Galatea Trunk Show CHICAGO, IL -- 11/22/09 --
With the coming holidays, why give the same
gift that everyone else is giving when you can come by Radiance Fine
Jewelry and get something truly special. "Galatea Jewelry by Artist" has
created some of the most unique pie..
The Grove’s Annual Tree Lighting Celebration and Concert, Sponsored by Cadillac, Features Special Performances, Celebrity Appearances, Lighting of the 100-ft Tree and Spectacular Fireworks Finale LOS ANGELES -
The Grove will host its annual tree-lighting event, “Hollywood Christmas
Celebration at The Grove” on Sunday, November 22 at 7:30 p.m. The
festive celebration, free to the public, draws crowds from throughout
Los Angeles who come to see the stunning 100-foot Christm
Doctors Day Announces Exclusive Miniature Stethoscope Lapel Pin for Doctor Gift and Nurse Gift
The National Doctors' Day organization today announced the introduction of its miniature stethoscope lapel pin. At only 3/4 inches in height, it is the first realistic stethoscope lapel pin that is small enough to truly be considered a lapel pin. Unique gifts for doctors are difficult to fin...
Zultys Appoints Alloy as Australian Distributor MELBOURNE, AUSTRALIA and SUNNYVALE, CA -- 11/22/09 --
Zultys, Inc., the
leading provider of elegantly simple
DopeStats.com Provides Statistical Information on Legal and Illegal Drugs in Each U.S. County
Information about drug use and drug information is now just a click away with the recently launched DopeStats.com. The new site is an online statistical database documenting drug use in more than 3,000 counties in the United States. The data is compiled by anonymous users on drugs and herbs f...
Rentrak Announces Box Office Numbers for Weekend of November 20, 2009
LOS ANGELES, Nov. 22 -- Rentrak Corporation (Nasdaq: RENT), today announced the weekend theatrical box office estimates for the weekend period of November 20 through November 22, 2009 according to the company's
|
|
|
|
|
|
|
|
|